倍他乐克联合5-单硝酸异山梨酯治疗心绞痛患者的临床疗效  

The Clinical Effect of Combined with 5-in Treatment of Angina Pectoris

作　　者：何永祥 

机构地区：[1]云南省曲靖市第二人民医院,云南曲靖655000

出　　处：《中国药物经济学》2016年第3期49-50,共2页China Journal of Pharmaceutical Economics

摘　　要：目的探讨倍他乐克联合5-单硝酸异山梨酯治疗心绞痛患者的临床疗效。方法选取2010年1月至2015年1月云南省曲靖市第二人民医院门诊确诊的80例心绞痛患者作为研究对象,按随机数字表法将其分为对照组和观察组,各40例。对照组患者予以5-单硝酸异山梨酯进行治疗,观察组患者在对照组基础上口服倍他乐克,比较两组患者的临床疗效及不良反应发生情况。结果观察组患者治疗的总有效率明显高于对照组,差异有统计学意义(P<0.05);观察组患者治疗后的不良反应发生率明显低于对照组,差异有统计学意义(P<0.05)。结论倍他乐克联合5-单硝酸异山梨酯治疗心绞痛患者疗效确切,治疗后不良反应少。Objective To observe the clinical effect of combined with 5- in treatment of angina pectoris.Methods From to January 2010,80 patients with angina pectoris were randomly divided into control group and observation group by random number table method,40 cases in to January 2015.The control group were treated with 5-alone,the observation group was treated with the control group.The clinical efficacy and adverse reactions of the two groups were compared.Results The total effective rate of the observation group was significantly higher than that of the control group,the difference was statistically significant（P〈0.05）;the incidence of adverse reactions in the observation group was significantly lower than that in the control group,the difference was statistically significant（P〈0.05）. Conclusion The combination of and 5-in the treatment of angina pectoris patients with definite curative effect,less adverse reactions.

关 键 词：倍他乐克 5-单硝酸异山梨酯 心绞痛 

分 类 号：R541.4[医药卫生—心血管疾病]